🇺🇸 FDA
Patent

US 10953026

N-acetyl mannosammine as a therapeutic agent

granted A61KA61K31/7008A61K31/7012

Quick answer

US patent 10953026 (N-acetyl mannosammine as a therapeutic agent) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/7008, A61K31/7012, A61P, A61P13/12